Literature DB >> 16306191

Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis.

Chien-Chang Chen1, Steve Louie, Hai Ning Shi, W Allan Walker.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a common pathogen in infantile diarrhea, causing a characteristic histopathologic attaching and effacing (A/E) lesion in the intestinal mucosa. The mouse pathogen Citrobacter rodentium causes a similar A/E lesion in the murine intestine. Like EPEC, C. rodentium infection results in colonic crypt hyperplasia, goblet cell depletion, epithelial proliferation, and mucosal disruption. Using this murine model, we tested the hypothesis that preinoculation of murine gut with Lactobacillus acidophilus early in life can enhance host defense against enteric bacterial infection and attenuate bacteria-mediated colitis. Two-week old BALB/c mice were inoculated with L. acidophilus twice per week for 4 weeks before C. rodentium infection or concomitantly with the exposure to C. rodentium at 6-8 weeks of age. The probiotics were administered twice weekly thereafter. We observed that L. acidophilus inoculation in mice inhibits C. rodentium-induced colitis, which is associated with a decrease in C. rodentium colonization and translocation, an increase in its clearance, and a suppression of colonic myeloperoxidase (MPO) activity. Probiotic treatment also stimulates regulatory cytokine expression in the colon [transforming growth factor beta (TGF-beta), interleukin (IL)-10]. Preinoculation with L. acidophilus is more effective than concomitant use of probiotics in the induction of intestinal IgA secretion and in the downregulation of proinflammatory cytokine expression [tumor necrosis factor alpha (TNF-alpha), IL-6, and IL-12]. These observations suggest that inoculation with probiotics can effectively prevent bacteria-induced colitis by limiting enteric bacteria infection and promoting mucosal protective regulatory immune responses. This study may have ramifications for prevention of infectious diarrhea in human infants and children, particularly in developing countries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306191     DOI: 10.1203/01.pdr.0000183660.39116.83

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  34 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; James P Nataro; Beth A McCormick; Karen A Krogfelt
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

Review 3.  Probiotics manipulate host cytokine response and induce antimicrobial peptides.

Authors:  I Trebichavský; I Splíchal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.

Authors:  Chien-Chang Chen; Cheng-Hsun Chiu; Tzou-Yien Lin; Hai Ning Shi; W Allan Walker
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

5.  Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.

Authors:  Anoop Kumar; Arivarasu N Anbazhagan; Hayley Coffing; Ishita Chatterjee; Shubha Priyamvada; Tarunmeet Gujral; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-15       Impact factor: 4.052

6.  Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.

Authors:  Caroline M Percopo; Tyler A Rice; Todd A Brenner; Kimberly D Dyer; Janice L Luo; Kishore Kanakabandi; Daniel E Sturdevant; Stephen F Porcella; Joseph B Domachowske; Jesse D Keicher; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2015-07-02       Impact factor: 5.970

7.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions.

Authors:  Sergey R Konstantinov; Hauke Smidt; Willem M de Vos; Sven C M Bruijns; Satwinder Kaur Singh; Florence Valence; Daniel Molle; Sylvie Lortal; Eric Altermann; Todd R Klaenhammer; Yvette van Kooyk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

9.  Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice.

Authors:  Helen Y Lau; Gary B Huffnagle; Thomas A Moore
Journal:  Microbes Infect       Date:  2008-08-13       Impact factor: 2.700

10.  Lactobacillus acidophilus attenuates downregulation of DRA function and expression in inflammatory models.

Authors:  Varsha Singh; Anoop Kumar; Geetu Raheja; Arivarasu N Anbazhagan; Shubha Priyamvada; Seema Saksena; Muhammad Nauman Jhandier; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.